Mga Batayang Estadistika
| CIK | 1317880 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Plandaí Biotechnology, Inc.
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| March 20, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED: September 30, 2016 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-51206 PLANDAÍ BIOTECHNOLOG |
|
| March 20, 2023 |
Exhibit 20.1 I, Tad Mailander, declare: 1. I am an attorney at law, duly licensed to practice before the Courts in the State of California. I am a member of the bar of the United States District Court for the State of California and the United States Court of Appeals for the Ninth U.S. Circuit. I am qualified to practice before the U.S. Securities and Exchange Commission. I have personal knowledge |
|
| March 16, 2023 |
Exhibit 20.1 I, Tad Mailander, declare: 1. I am an attorney at law, duly licensed to practice before the Courts in the State of California. I am a member of the bar of the United States District Court for the State of California and the United States Court of Appeals for the Ninth U.S. Circuit. I am qualified to practice before the U.S. Securities and Exchange Commission. I have personal knowledge |
|
| March 16, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2016 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 000-51206 PLANDAÍ BIOTECHNOLOGY, INC. (Name of small business issuer in |
|
| February 15, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 6)* PLANDAI BIOTECHNOLOGY, INC. (Name of Issuer) Common Stock $0.0001 par value (Title of Class of Securities) 72703D100 (CUSIP Number) February 14, 2022 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rul |
|
| January 27, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 5)* PLANDAI BIOTECHNOLOGY, INC. (Name of Issuer) Common Stock $0.0001 par value (Title of Class of Securities) 72703D100 (CUSIP Number) December 31, 2020 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rul |
|
| January 21, 2021 |
Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Plandai Biotechnology Inc (Name of Issuer) Common Stock (Title of Class of Securities) 72703D100 (CUSIP Number) January 21, 2021 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sche |
|
| February 13, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 4)* PLANDAI BIOTECHNOLOGY, INC. (Name of Issuer) Common Stock $0.0001 par value (Title of Class of Securities) 72703D100 (CUSIP Number) December 31, 2019 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rul |
|
| February 15, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 3)* PLANDAI BIOTECHNOLOGY, INC. (Name of Issuer) Common Stock $0.0001 par value (Title of Class of Securities) 72703D100 (CUSIP Number) December 31, 2018 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rul |
|
| February 14, 2018 |
PLPL / Plandai Biotechnology, Inc. / Black Mountain Equities, Inc. Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Plandai Biotechnology, Inc. (Name of Issuer) Common Stock $0.0001 par value (Title of Class of Securities) 72703D100 (CUSIP Number) January 3, 2018 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designate the rule |
|
| April 24, 2017 |
PLPL / Plandai Biotechnology, Inc. / EMA Financial, LLC - SCHEDULE 13G/A2 Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 2) Plandai Biotechnology, Inc. (Name of Issuer) Common Stock $0.0001 par value (Title of Class of Securities) 72703D100 (CUSIP Number) April 19, 2017 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pu |
|
| February 1, 2017 |
PLPL / Plandai Biotechnology, Inc. / EMA Financial, LLC - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* Plandai Biotechnology, Inc. (Name of Issuer) Common Stock $0.0001 par value (Title of Class of Securities) 72703D100 (CUSIP Number) December 31, 2016 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rul |
|
| January 31, 2017 |
Plandai Biotechnology FORM 15-12G OMB APPROVAL OMB Number: 3235-0167 Expires: March 31, 2018 Estimated average burden hours per response . |
|
| September 28, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: October 31, 2018 Estimated average burden hours per response ... 2.50 000-51206 SEC FILE NUMBER (Check one): ? Form 10-K o Form 20-F o Form 11-K o Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: June 30, 2016 o Transition Repo |
|
| September 27, 2016 |
PLPL / Plandai Biotechnology, Inc. / EMA Financial, LLC - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Plandai Biotechnology, Inc. (Name of Issuer) Common Stock $0.0001 par value (Title of Class of Securities) 72703D100 (CUSIP Number) September 19, 2016 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule |
|
| September 21, 2016 | ||
| September 21, 2016 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 (Date of Report) (Date of earliest event reported): September 15, 2016 PLANDAI BIOTECHNOLOGY, INC. (Exact Name of Registrant as Specified in its Charter) Nevada 000-51206 20-1389815 (State or other jurisdiction of incorporation) (Commission File Number) (I |
|
| September 1, 2016 |
PLPL / Plandai Biotechnology, Inc. / UNION CAPITAL, LLC - SCHEDULE 13G Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Plandai Biotechnology, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 72703D100 (CUSIP Number) August 31, 2016 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sch |
|
| August 17, 2016 |
Plandai Biotechnology FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED: March 31, 2016 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-51206 PLANDA? BIOTECHNOLOG |
|
| August 11, 2016 |
Plandai Biotechnology FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED: December 31, 2015 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-51206 PLANDA? BIOTECHNO |
|
| July 29, 2016 |
Plandai Biotechnology FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED: September 30, 2015 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-51206 PLANDA? BIOTECHN |
|
| June 30, 2016 |
Plandai Biotechnology FORM 10-K (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2015 ? TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 000-51206 PLANDA? BIOTECHNOLOGY, INC. (Name of small business issuer in |
|
| May 17, 2016 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K/A Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 (Date of Report) (Date of earliest event reported): April 20, 2016 PLANDAI BIOTECHNOLOGY, INC. (Exact Name of Registrant as Specified in its Charter) Nevada 000-51206 20-1389815 (State or other jurisdiction of incorporation) (Commission File Number) (I.R |
|
| May 17, 2016 |
MAILANDER LAW OFFICE, INC. 835 5th Avenue, Ste. 312 San Diego, California 92101 (619) 239-9034 May 17, 2016 U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D. C. 20549-7010 ATTN: Ms. Sharon Blume Branch Chief, Office of Health Car & Insurance Re: Plandai Biotechnology, Inc. Item 4.02 Form 8-K Filed April 27,2016 File No. 000-51206 Dear Ms. Blu |
|
| May 17, 2016 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K/A Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 (Date of Report) (Date of earliest event reported): April 20, 2016 PLANDAI BIOTECHNOLOGY, INC. (Exact Name of Registrant as Specified in its Charter) Nevada 000-51206 20-1389815 (State or other jurisdiction of incorporation) (Commission File Number) (I.R |
|
| April 27, 2016 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 (Date of Report) (Date of earliest event reported): April 20, 2016 PLANDAI BIOTECHNOLOGY, INC. (Exact Name of Registrant as Specified in its Charter) Nevada 000-51206 20-1389815 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S |
|
| April 27, 2016 |
Exhibit 16.1 April 25, 2016 Securities and Exchange Commission 100 F. Street Washington, DC 20549 - 7561 Re: Plandai Biotechnology, Inc. Commission File No. 000 - 51206 We have read the statements that we understand Plandai Biotechnology, Inc. will include under Item 4.01 of the Form 8-K report dated April 27, 2016 and agree with such statements in so far as they apply to our firm. We have no basi |
|
| March 2, 2016 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 (Date of Report) (Date of earliest event reported): February 29, 2016 PLANDAI BIOTECHNOLOGY, INC. (Exact Name of Registrant as Specified in its Charter) Nevada 000-51206 20-1389815 (State or other jurisdiction of incorporation) (Commission File Number) (I. |
|
| March 2, 2016 |
February 19, 2016 Board of Directors Planda? Biotechnology, Inc. Gentlemen: Please accept this letter representing my resignation as Director of the Company effective as of the close of business on February 29, 2016. My resignation does not reflect any disagreement with management or the direction of the Company but, rather, reflects my focus on other business opportunities that limit the time I c |
|
| November 16, 2015 |
NT 10-Q 1 plplform2b2593015.htm NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: October 31, 2018 Estimated average burden hours per response ... 2.50 000-51206 SEC FILE NUMBER (Check one): o Form 10-K o Form 20-F o Form 11-K ý Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Perio |
|
| October 9, 2015 |
Changes in Registrant's Certifying Accountant SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 6, 2015 PLANDA? BIOTECHNOLOGY, INC. (Exact Name of Registrant as Specified in its Charter) Nevada (State or other jurisdiction of incorporation or organization) 000-51206 Commission File Nu |
|
| September 28, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: September 30, 2015 Estimated average burden hours per response ... 2.50 000-51206 SEC FILE NUMBER (Check one): ? Form 10-K o Form 20-F o Form 11-K o Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: June 30, 2015 o Transition Re |
|
| September 25, 2015 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 21, 2015 PLANDA? BIOTECHNOLOGY, INC. (Exact Name of Registrant as Specified in its Charter) Nevada (State or other jurisdiction of incorporation or organization) Commission File Number 00 |
|
| September 25, 2015 |
Danielle M. Adams, CPA Adams Advisory, LLC Encinitas, California 92024 EXHIBIT 16.1 Danielle M. Adams, CPA Adams Advisory, LLC Encinitas, California 92024 September 23, 2015 Office of the Chief Accountant Securities and Exchange Commission 100F Street, NE Washington, D.C. 20549 Dear Sir/Madam: We have read the statements made by PLANDAI BIOTECHNOLOGY, INC., which were provided to us and which we understand will be filed with the Commission pursuant to Item 4.01 of it |
|
| June 15, 2015 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 8, 2015 PLANDA? BIOTECHNOLOGY, INC. (Exact Name of Registrant as Specified in its Charter) Nevada (State or other jurisdiction of incorporation or organization) Commission File Number 000-51 |
|
| June 10, 2015 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 8, 2015 PLANDA? BIOTECHNOLOGY, INC. (Exact Name of Registrant as Specified in its Charter) Nevada (State or other jurisdiction of incorporation or organization) Commission File Number 000-5120 |
|
| May 20, 2015 | ||
| May 20, 2015 | ||
| May 20, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED: March 31, 2015 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-51206 PLANDA? BIOTECHNOLOG |
|
| May 15, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: August 31, 2015 Estimated average burden hours per response ... 2.50 000-51206 SEC FILE NUMBER (Check one): o Form 10-K o Form 20-F o Form 11-K ? Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: March 31, 2015 o Transition Repo |
|
| April 28, 2015 |
EXHIBIT 16.1 TERRY L. JOHNSON, CPA 406 Greyford Lane Casselberry, Florida 32707 Phone 407-721-4753 Fax/Voice Message 866-813-3428 E-mail [email protected] April 22, 2015 Office of the Chief Accountant Securities and Exchange Commission 100F Street, NE Washington, D.C. 20549 Dear Sir/Madam: We have read the statements made by PLANDA? BIOTECHNOLOGY, INC., which were provided to us and which we unders |
|
| April 28, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 22, 2015 PLANDA? BIOTECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Nevada 000-51206 45-3642179 (State or other jurisdiction of incorporation) (Commissio |
|
| February 12, 2015 | ||
| February 12, 2015 | ||
| February 12, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED: December 31, 2014 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-51206 PLANDA? BIOTECHNO |
|
| February 12, 2015 | ||
| February 12, 2015 | ||
| February 12, 2015 | ||
| February 12, 2015 | ||
| February 12, 2015 | ||
| February 12, 2015 | ||
| February 11, 2015 |
PLPL / Plandai Biotechnology, Inc. CORRESP - - Plandai Biotechnology, Inc. 1451 North 200 East, Suite 130C Logan, UT 98102 February 11, 2015 Jeffrey P. Riedler Assistant Director United States Securities and Exchange Commission Washington, DC 20549 Re: Plandai Biotechnology, Inc. Registration Statement on Form S-3 Filed January 21, 2015 and as amended February 9, 2015 File No. 333-201632 Dear Mr. Riedler: Plandai Biotechnology, Inc. hereby req |
|
| February 9, 2015 |
PLPL / Plandai Biotechnology, Inc. S-3/A - - FORM S-3/A As filed with the Securities and Exchange Commission on February 9, 2015 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| January 21, 2015 |
PLPL / Plandai Biotechnology, Inc. S-3 - - FORM S-3 As filed with the Securities and Exchange Commission on January 21, 2015 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| November 14, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED: September 30, 2014 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-51206 PLANDA? BIOTECHN |
|
| October 14, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2014 ? TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 000-51206 PLANDA? BIOTECHNOLOGY, INC. (Name of small business issuer in |
|
| September 29, 2014 |
PLPL / Plandai Biotechnology, Inc. NT 10-K - - NT 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: August 31, 2015 Estimated average burden hours per response ... 2.50 000-51206 SEC FILE NUMBER (Check one): ý Form 10-K o Form 20-F o Form 11-K o Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: June 30, 2014 o Transition Repor |
|
| September 9, 2014 |
Termination of a Material Definitive Agreement SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 4, 2014 PLANDAÍ BIOTECHNOLOGY, INC. (Exact Name of Registrant as Specified in its Charter) Nevada (State or other jurisdiction of incorporation or organization) Commission File Number 000 |
|
| May 14, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED: March 31, 2014 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-51206 PLANDA? BIOTECHNOLOG |
|
| April 29, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (Amendment No. 2) (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2013 ¨ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 000-51206 PLANDAÍ BIOTECHNOLOGY, INC. (Name of small |
|
| April 29, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (Amendment No. 2) (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2013 ? TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 000-51206 PLANDA? BIOTECHNOLOGY, INC. (Name of small |
|
| March 24, 2014 |
March 24, 2014 Securities and Exchange Commission Division of Corporate Finance Washington D. |
|
| March 17, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K /A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 22, 2014 PLANDAÍ BIOTECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Nevada 000-51206 20-1389815 (State or other jurisdiction of incorporation) (Comm |
|
| February 19, 2014 |
AMENDMENT NO. 1 TO REGISTRATION RIGHTS AGREEMENT AMENDMENT NO. 1 TO REGISTRATION RIGHTS AGREEMENT This Amendment No. 1 (this “Amendment”) to that certain Registration Rights Agreement, dated as of February 4, 2014 (the “Agreement”), by and between PLANDAÍ BIOTECHNOLOGY, INC., a Nevada corporation (the “Company”), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (the “Investor”), is entered into as of February 19, 2014 (t |
|
| February 19, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED: December 31, 2013 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-51206 PLANDAÍ BIOTECHNO |
|
| February 14, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: August 31, 2015 Estimated average burden hours per response ... 2.50 000-51206 SEC FILE NUMBER (Check one): o Form 10-K o Form 20-F o Form 11-K ý Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: December 31, 2013 o Transition R |
|
| February 13, 2014 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 February 12, 2014 (Date of Report) PLANDAI BIOTECHNOLOGY, INC. (Exact Name of Registrant as Specified in its Charter) Nevada 000-51206 20-1389815 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 2 |
|
| February 10, 2014 |
Execution Version PURCHASE AGREEMENT PURCHASE AGREEMENT (the “Agreement”), dated as of February 4, 2014, by and between PLANDAÍ BIOTECHNOLOGY, INC. |
|
| February 10, 2014 |
Execution Version REGISTRATION RIGHTS AGREEMENT REGISTRATION RIGHTS AGREEMENT (this "Agreement"), dated as of February 4, 2014, by and between PLANDAÍ BIOTECHNOLOGY, INC. |
|
| February 10, 2014 |
Plandaí Biotechnology Completes $15.3 Million Funding Commitment with Institutional Investor Enters in to Stock Purchase Agreement with Lincoln Park Capital Fund NEW YORK, NY, February 10, 2014 – Plandaí Biotechnology, Inc. (OTCQB:PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical, and pharmaceutical, announced today that it has entered |
|
| February 10, 2014 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 February 4, 2014 (Date of Report) PLANDAI BIOTECHNOLOGY, INC. (Exact Name of Registrant as Specified in its Charter) Nevada 000-51206 20-1389815 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 22 |
|
| January 23, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 22, 2014 PLANDAÍ BIOTECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Nevada 000-51206 20-1389815 (State or other jurisdiction of incorporation) (Commiss |
|
| January 23, 2014 |
Patrick Rodgers, CPA, PA 309 E. Citrus Street Altamonte Springs, FL 32701 Patrick Rodgers, CPA, PA 309 E. Citrus Street Altamonte Springs, FL 32701 January 22, 2014 Securities & Exchange Commission 100 F Street NE Mail Stop 6010 Washington, DC 20549 Dear Sir/Madam: Plandai Biotechnology, Inc. has made available to me a copy of its Current Report on Form 8-K, dated January 22, 2014 in which it provides information pursuant to item 4.01 with regard to “Changes in Registra |
|
| November 27, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2013 ? TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 000-51206 PLANDA? BIOTECHNOLOGY, INC. (Name of small business issuer i |
|
| November 19, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED: September 30, 2013 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-51206 PLANDA? BIOTECHN |
|
| November 14, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: August 31, 2015 Estimated average burden hours per response ... 2.50 000-51206 SEC FILE NUMBER (Check one): o Form 10-K o Form 20-F o Form 11-K ý Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: September 30, 2013 o Transition |
|
| November 12, 2013 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 November 11, 2013 (Date of Report) PLANDAI BIOTECHNOLOGY, INC. (Exact Name of Registrant as Specified in its Charter) Nevada 000-51206 20-1389815 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 2 |
|
| September 30, 2013 | ||
| September 30, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2013 ? TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 000-51206 PLANDA? BIOTECHNOLOGY, INC. (Name of small business issuer in |
|
| August 30, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 August 30, 2013 (Date of Report) PLANDAÍ BIOTECHNOLOGY, INC. (Exact Name of Registrant as Specified in its Charter) Nevada 000-51206 20-1389815 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identific |
|
| June 6, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A (MARK ONE) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED: December 31, 2012 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-51206 PLANDA? BIOTECH |
|
| May 20, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED: March 31, 2013 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-51206 PLANDA? BIOTECHNOLOG |
|
| May 15, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER: 000-51206 NOTIFICATION OF LATE FILING (Check One) ¨ Form 10-K ¨ Form 20-F ¨ Form 11-K x Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Year Ended: March 31, 2013 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 10-Q |
|
| February 14, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED: December 31, 2012 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-51206 PLANDA? BIOTECHNO |
|
| February 13, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 8, 2013 PLANDAÍ BIOTECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Nevada 000-51206 45-3642179 (State or other jurisdiction of incorporation) (Commiss |
|
| December 7, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 3, 2012 PLANDAÍ BIOTECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Nevada 000-51206 45-3642179 (State or other jurisdiction of incorporation) (Commiss |
|
| December 7, 2012 |
Exhibit 16.1 Michael F. Cronin, CPA 687 Lee Road, Ste 210 Rochester, NY 14606 407-754-7027 Email: [email protected] 1574 Eagle Nest Circle Winter Springs, FL 32708 December 3, 2012 Securities & Exchange Commission 100 F Street NE Mail Stop 6010 Washington, DC 20549 Dear Sir/Madam: Name of Company, Inc. has made available to me a copy of its Current Report on Form 8-K, dated December 7, 2012 in whic |
|
| November 19, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED: September 30, 2012 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-51206 PLANDA? BIOTECHN |
|
| November 14, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12B-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 000-51206 (Check One): [ ] Form 10-K [ ] Form 11-K [ ] Form 20-F [X] Form 10-Q [ ] Form N-SAR For Period Ended: September 30, 2012 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10-Q [ |
|
| October 15, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2012 ? TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 000-51206 PLANDA? BIOTECHNOLOGY, INC. (Name of small business issuer in |
|
| October 9, 2012 |
Completion of Acquisition or Disposition of Assets - FORM 8-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K/A Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 November 23, 2011 (Date of Report) PLANDAÍ BIOTECHNOLOGY, INC. (Exact Name of Registrant as Specified in its Charter) Nevada 000-51206 45-3642179 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Ident |
|
| September 28, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12B-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 000-51206 (Check One): [ X ] Form 10-K [ ] Form 11-K [ ] Form 20-F [ ] Form 10-Q [ ] Form N-SAR For Period Ended: June 30, 2012 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10-Q [ ] |
|
| September 27, 2012 |
EXHIBIT 16.1 ROBISON, HILL & CO. Certified Public Accountants A PROFESSIONAL CORPORATION DAVID O. SEAL, CPA W. DALE WESTENSKOW, CPA BARRY D. LOVELESS, CPA STEPHEN M. HALLEY, CPA September 27, 2012 U.S. Securities and Exchange Commission Office of the Chief Accountant 100 F Street NE Washington, DC 20549 Re: Plandai Biotechnology, Inc. Ladies and Gentlemen: We have read the statements under item 4. |
|
| September 27, 2012 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported): August 23, 2012 PLANDAÍ BIOTECHNOLOGY, INC. (Exact name of registrant as specified in its charter) Nevada 000-51206 20-1389815 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Em |
|
| July 6, 2012 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K/A (Amendment No. 1) Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 November 23, 2011 (Date of Report) PLANDAÍ BIOTECHNOLOGY, INC. (Exact Name of Registrant as Specified in its Charter) Nevada 000-51206 20-1389815 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer I |
|
| May 21, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED: MARCH 31, 2012 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-51206 PLANDA? BIOTECHNOLOG |
|
| May 15, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12B-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 000-51206 (Check One): [ ] Form 10-K [ ] Form 11-K [ ] Form 20-F [X] Form 10-Q [ ] Form N-SAR For Period Ended: March 31, 2012 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10-Q [ ] T |
|
| May 7, 2012 |
LAND BANK We stand by you TERM LOAN FACILITY AGREEMENT entered into between THE LAND AND AGRICULTURAL DEVELOPMENT BANK OF SOUTH AFRICA (governed by the Land and Agricultural Development Bank Act No. |
|
| May 7, 2012 |
LAND BANK We stand by you TERM LOAN FACILITY AGREEMENT entered into between THE LAND AND AGRICULTURAL DEVELOPMENT BANK OF SOUTH AFRICA (governed by the Land and Agricultural Development Bank Act No. |
|
| May 7, 2012 |
LAND BANK We stand by you PROFIT SHARE AGREEMENT entered into between LAND AND AGRICULTURAL DEVELOPMENT BANK OF SOUTH AFRICA (“Land Bank”) and GREEN GOLD BIOTECHNOLOGIES (PROPRIETARY) LIMITED (REGISTRATION NUMBER: 2010/018613/07) (“of the”) 2 TABLE OF CONTENTS Clause number and description Page TABLE OF CONTENTS 2 1. |
|
| May 7, 2012 |
LAND BANK SECURITY CESSION OF ALL AMOUNTS OWING entered into between THE LAND AND AGRICULTURAL DEVELOPMENT BANK OF SOUTH AFRICA governed by the Land and Agricultural Development Bank Act 15 of 2002 and THE CEDENT (as defined in the Schedule) 2 1. |
|
| May 7, 2012 |
LAND BANK SECURITY CESSION OF ALL AMOUNTS OWING entered into between THE LAND AND AGRICULTURAL DEVELOPMENT BANK OF SOUTH AFRICA governed by the Land and Agricultural Development Bank Act 15 of 2002 and THE CEDENT (as defined in the Schedule) 2 1. |
|
| May 7, 2012 |
LAND BANK We stand by you SECURITY CESSION OF INSURANCES entered into between THE LAND AND AGRICULTURAL DEVELOPMENT BANK OF SOUTH AFRICA governed by the Land and Agricultural Development Bank Act 15 of 2002 and THE CEDENT (as defined in the Schedule) 2 1. |
|
| May 7, 2012 |
LAND BANK We stand by you REVOLVING LOAN FACILITY AGREEMENT entered into between THE LAND AND AGRICULTURAL DEVELOPMENT BANK OF SOUTH AFRICA (governed by the Land and Agricultural Development Bank Act, 15 of 2002) and THE BORROWER (whose details are set out in Schedule 1) WHEREBY IT IS AGREED AS FOLLOWS: 1. |
|
| May 7, 2012 |
LAND BANK We stand by you PROFIT SHARE AGREEMENT entered into between LAND AND AGRICULTURAL DEVELOPMENT BANK OF SOUTH AFRICA (“Land Bank”) and BREAKWOOD TRADING 22 (PROPRIETARY) LIMITED (REGISTRATION NUMBER: 2010/016073/07) (“theCompany”) 2 TABLE OF CONTENTS Clause number and description Page TABLE OF CONTENTS 2 1. |
|
| May 7, 2012 |
LAND BANK SECURITY CESSION OF LEASES entered into between THE LAND AND AGRICULTURAL DEVELOPMENT BANK OF SOUTH AFRICA governed by the Land and Agricultural Development Bank Act 15 of 2002 and THE CEDENT (as defined in the Schedule) 2 1. |
|
| May 7, 2012 |
LAND BANK SECURITY CESSION OF ALL AMOUNTS OWING entered into between THE LAND AND AGRICULTURAL DEVELOPMENT BANK OF SOUTH AFRICA governed by the Land and Agricultural Development Bank Act 15 of 2002 and THE CEDENT (as defined in the Schedule) 2 1. |
|
| May 7, 2012 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 April 27, 2012 (Date of Report) PLANDAI BIOTECHNOLOGY, INC. (Exact Name of Registrant as Specified in its Charter) Nevada 000-51206 20-1389815 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 2226 |
|
| May 7, 2012 |
LAND BANK We stand by you REVOLVING LOAN FACILITY AGREEMENT entered into between THE LAND AND AGRICULTURAL DEVELOPMENT BANK OF SOUTH AFRICA (governed by the Land and Agricultural Development Bank Act, 15 of 2002) and THE BORROWER (whose details are set out in Schedule 1) WHEREBY IT IS AGREED AS FOLLOWS: 1. |
|
| May 7, 2012 |
LAND BANK We stand by you SECURITY CESSION OF INSURANCES entered into between THE LAND AND AGRICULTURAL DEVELOPMENT BANK OF SOUTH AFRICA governed by the Land and Agricultural Development Bank Act 15 of 2002 and THE CEDENT (as defined in the Schedule) 2 1. |
|
| May 4, 2012 |
Plandaí Biotechnology Inc. “Unlocking Nature’s Secrets”™ • Safe Harbor Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors. This presentation is not intended for gen |
|
| May 4, 2012 |
begin 644 plplinvestordeck.pdf M)5!$1BTQ+C8-)>+CS],-"C7!E+T]B:E-T;3X^ M<0Z17P((6/'P!ZS3K%$\`>;4A,$ M*2GH%"3-4U(0"CGB1P5).)RJ=A)T%(M3N+29^@7@8T5YEH0B(AAL@@B1@61 M013?*5-*N&PP):4"PM5(Q5&"8A7?B2"J$VE*I@D$Y.39"04!ORW!W#([`QF2`"1(5!@+GP&D4`@1B:(9TQ.*%QRP\3<-P/17()` M*2"*@*B3J%]62%:$S1227;,I)%MQ`I*SRU%(+M!LB*%XQ$PAN;J#FB>=W1TM M(-Q!N*3!W;$9A#N(1&IT=Q!BC>Z@I4F3NV,"PAW$KHJ[8P;"'42JM%EHD*SN M(+*LYG%&RC7#;P |
|
| May 4, 2012 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 May 3, 2012 (Date of Report) PLANDAI BIOTECHNOLOGY, INC. (Exact Name of Registrant as Specified in its Charter) Nevada 000-51206 20-1389815 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 2226 Ea |
|
| March 23, 2012 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 March 23, 2012 (Date of Report) PLANDAI BIOTECHNOLOGY, INC. (Exact Name of Registrant as Specified in its Charter) Nevada 000-51206 20-1389815 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 2226 |
|
| February 21, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED: DECEMBER 31, 2011 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-51206 PLANDA? BIOTECHNO |
|
| February 14, 2012 |
NT 10-Q 1 plpl12b2512312011.htm NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12B-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 000-51206 (Check One): [ ] Form 10-K [ ] Form 11-K [ ] Form 20-F [X] Form 10-Q [ ] Form N-SAR For Period Ended: December 31, 2011 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11 |
|
| January 9, 2012 |
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 January 5, 2012 (Date of Report) Plandai Biotechnology, Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 000-51206 20-1389815 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identific |
|
| November 23, 2011 |
SHARE EXCHANGE AGREEMENT This Share Exchange Agreement (the ?Agreement?) is effective as of the 28th day of October, 2011 (the ?Effective Date?), BETWEEN: Plandai Biotechnologies, Inc. |
|
| November 23, 2011 |
Completion of Acquisition or Disposition of Assets SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934 November 23, 2011 (Date of Report) DIAMOND RANCH FOODS, LTD. (Exact Name of Registrant as Specified in its Charter) Nevada 000-51206 20-1389815 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 222 |
|
| November 23, 2011 | ||
| November 16, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED: SEPTEMBER 30, 2011 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-51206 DIAMOND RANCH FO |
|
| November 14, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12B-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 000-51206 (Check One): [ ] Form 10-K [ ] Form 11-K [ ] Form 20-F [X] Form 10-Q [ ] Form N-SAR For Period Ended: September 30, 2011 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10-Q [ |
|
| August 22, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED: JUNE 30, 2011 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-51206 DIAMOND RANCH FOODS, |
|
| August 15, 2011 |
NT 10-Q 1 drfo12b2506302011.htm NT-10Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12B-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 000-51206 (Check One): [ ] Form 10-K [ ] Form 11-K [ ] Form 20-F [X] Form 10-Q [ ] Form N-SAR For Period Ended: June 30, 2011 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ |
|
| July 20, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A AMENDMENT NO. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A AMENDMENT NO. 1 (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2011 ? TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 000-51206 DIAMOND RANCH FOODS, LTD. (Name of small bu |
|
| July 20, 2011 |
Exhibit 21 LIST OF SUBSIDIARIES 1. Executive Seafood, Inc. |
|
| July 14, 2011 |
Exhibit 21 LIST OF SUBSIDIARIES 1. Executive Seafood, Inc. |
|
| July 14, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2011 ? TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 000-51206 DIAMOND RANCH FOODS, LTD. (Name of small business issuer in i |
|
| June 29, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12B-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 000-51206 (Check One): [ X ] Form 10-K [ ] Form 11-K [ ] Form 20-F [ ] Form 10-Q [ ] Form N-SAR For Period Ended: March 31, 2011 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10-Q [ ] |
|
| February 8, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED: DECEMBER 31, 2010 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-51206 DIAMOND RANCH FOO |
|
| January 25, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report ( Date of earliest event reported): January 20, 2011 DIAMOND RANCH FOODS, LTD. (Exact name of registrant as specified in its charter) Nevada 000-51206 20-1389815 < p style="MARGIN:0px; FONT-SIZE:12pt" align=center>(Sta |
|
| January 25, 2011 |
EXHIBIT 16.1 January 25, 2011 U.S. Securities and Exchange Commission Office of the Chief Accountant 100 F Street NE Washington, DC 20549 Re: Diamond Ranch Foods. Ltd. Ladies and Gentleme n: We have read the statements under item 4.01 in the Form 8-K dated January 25, 2011, of Diamond Ranch Foods. Ltd. (the Company) to be filed with the Securities and Exchange Commission and we agree with such sta |
|
| November 19, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED: SEPTEMBER 30, 2010 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-51206 DIAMOND RANCH FO |
|
| November 15, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12B-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 000-51206 (Check One): [ ] Form 10-K [ ] Form 11-K [ ] Form 20-F [ X ] Form 10-Q [ ] Form N-SAR For Period Ended: September 30, 2010 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10-Q |
|
| October 8, 2010 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 30, 2010 DIAMOND RANCH FOODS, LTD. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation or organization) 000-51206 (Commission File Num |
|
| October 8, 2010 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Exhibit 16.1 October 6, 2010 Securities and Exchange Commission 450 Fifth Street, Northwest Washington, D.C. 20549 Re: Diamond Ranch Foods, Ltd. Form 8-K To the Securities and Exchange Commission: Please be advised that we have been presented with a copy of the Form 8-K (File No. 000-51206) of Diamond Ranch Foods, Ltd. (“Registrant”) and ha |
|
| September 10, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 7, 2010 DIAMOND RANCH FOODS, LTD. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation or organization) 000-51206 (Com |
|
| August 16, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED: JUNE 30, 2010 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-51206 DIAMOND RANCH FOODS, |
|
| July 16, 2010 |
July 15, 2010 Linda Cvrkel/Branch Chief United States Securities and Exchange Commission 100 F. |
|
| July 14, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K 10-K 1 drfoform10k33120102.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2010 ¨ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 000-51206 DIAMOND RANCH FOODS, LTD. (Nam |
|
| June 30, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12B-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 000-51206 (Check One): [ X ] Form 10-K [ ] Form 11-K [ ] Form 20-F [ ] Form 10-Q [ ] Form N-SAR For Period Ended: March 31, 2010 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10-Q [ ] |
|
| June 29, 2010 |
June 29, 2010 Linda Cvrkel/Branch Chief United States Securities and Exchange Commission 100 F. |
|
| June 2, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A Amendment No. 2 (MARK ONE) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED: JUNE 30, 2009 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-51206 DIA |
|
| June 2, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A Amendment No. 2 (MARK ONE) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED: DECEMBER 31, 2009 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-51206 |
|
| June 2, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A Amendment No. 2 (MARK ONE) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED: SEPTEMBER 30, 2009 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-5120 |
|
| June 2, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A Amendment No. 2 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A Amendment No. 2 (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2009 ? TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 000-51206 DIAMOND RANCH FOODS, LTD. (Name of small bu |
|
| June 1, 2010 |
June 2, 2010 Linda Cvrkel/Branch Chief United States Securities and Exchange Commission 100 F. |
|
| May 25, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 13, 2010 DIAMOND RANCH FOODS, LTD. (Exact name of registrant as specified in its charter) Nevada 20-1389815 (State or other jurisdiction of incorporation or organization (I.R. |
|
| May 5, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A Amendment No. 1 (MARK ONE) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED: SEPTEMBER 30, 2009 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-5120 |
|
| May 5, 2010 |
May 5, 2010 Linda Cvrkel/Branch Chief United States Securities and Exchange Commission 100 F. |
|
| May 5, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A Amendment No. 1 (MARK ONE) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED: JUNE 30, 2009 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-51206 DIA |
|
| May 5, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A Amendment No. 1 (MARK ONE) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED: DECEMBER 31, 2009 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-51206 |
|
| May 5, 2010 |
NITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A Amendment No. 1 NITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A Amendment No. 1 (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2009 ? TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 000-51206 DIAMOND RANCH FOODS, LTD. (Name of small bus |
|
| February 19, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED: DECEMBER 31, 2009 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-51206 DIAMOND RANCH FOO |
|
| February 16, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12B-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 000-51206 (Check One): [ ] Form 10-K [ ] Form 11-K [ ] Form 20-F [ X ] Form 10-Q [ ] Form N-SAR For Period Ended: December 31, 2009 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10-Q |
|
| November 16, 2009 |
10-Q 1 diamondranchfoodsform10q9300.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED: SEPTEMBER 30, 2009 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commissio |
|
| August 12, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED: JUNE 30, 2009 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-51206 DIAMOND RANCH FOODS, |
|
| July 6, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2009 ? TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 000-51206 DIAMOND RANCH FOODS, LTD. (Name of small business issuer in i |
|
| July 6, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12B-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 000-51206 (Check One): [X] Form 10-K [ ] Form 11-K [ ] Form 20-F [ ] Form 10-Q [ ] Form N-SAR For Period Ended: March 31, 2009 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10-Q [ ] T |
|
| February 12, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED: DECEMBER 31, 2008 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-51206 Diamond Ranch Foo |
|
| November 12, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED: SEPTEMBER 30, 2008 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-51206 Diamond Ranch Fo |
|
| August 14, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED: JUNE 30, 2008 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-51206 DIAMOND RANCH FOODS, |
|
| July 14, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-QSB/A Amendment No. 2 (MARK ONE) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED: JUNE 30, 2007 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-51206 D |
|
| July 14, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-KSB/A Amendment No. 2 (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2007 ? TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 000-51206 DIAMOND RANCH FOODS, LTD. (Name of small |
|
| July 14, 2008 |
July 12, 2008 Securities and Exchange Commission 100 F Street, N.E. Washington DC, 20549 Attn: Linda Cvrkel Re: Diamond Ranch Foods, Ltd. SEC Comment Letter dated June 18, 2008 Ms. Cvrkel: Please accept the following responses to your June 18, 2008 comment letter to Diamond Ranch Foods, Ltd. Please note that Registrant filed amended financial statements for the year ended March 31, 2007 and for th |
|
| July 14, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-QSB/A Amendment No. 2 (MARK ONE) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED: September 30, 2007 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-51 |
|
| July 14, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 11, 2008 DIAMOND RANCH FOODS, LTD. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation or organization) 000-51206 (Commiss |
|
| June 5, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-KSB UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-KSB (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2008 ? TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 000-51206 DIAMOND RANCH FOODS, LTD. (Name of small business issuer in |
|
| May 6, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-QSB/A (MARK ONE) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED: September 30, 2007 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-51206 Diamond Ranc |
|
| May 6, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-KSB/A 10KSB/A 1 dfdrform10ksba3312007.htm OPTIONAL FORM FOR ANNUAL AND TRANSITION REPORTS OF SMALL BUSINESS ISSUERS [SECTION 13 OR 15(D), NOT S-B ITEM 405] UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-KSB/A (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2007 ¨ TRANSITION REPORT UNDER |
|
| May 6, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-QSB/A (MARK ONE) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED: JUNE 30, 2007 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-51206 Diamond Ranch Foo |
|
| May 6, 2008 |
May 6, 2008 Securities and Exchange Commission 100 F Street, N.E. Washington DC, 20549 Attn: Linda Cvrkel Re: Diamond Ranch Foods, Ltd. SEC Comment Letter dated January 30, 2008 Ms. Cvrkel: Please accept the following responses to your January 30, 2008 comment letter to Diamond Ranch Foods, Ltd. Please note that Registrant filed amended financial statements for the year ended March 31, 2007 and fo |
|
| March 14, 2008 |
March 14, 2008 Securities and Exchange Commission 100 F Street, N.E. Washington DC, 20549 Attn: Linda Cvrkel Re: Diamond Ranch Foods, Ltd. SEC Comment Letter dated January 30, 2008 Ms. Cvrkel: In response to the Commission?s comment letter dated January 30, 2008 regarding the Form 10-KSB for the fiscal year ended March 31, 2007 filed on behalf of Diamond Ranch Foods, Ltd. on June 29, 2007, the Com |
|
| February 12, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-QSB (MARK ONE) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED: December 31, 2007 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-51206 Diamond Ranch F |
|
| February 6, 2008 |
February 6, 2008 Securities and Exchange Commission 100 F Street, N.E. Washington DC, 20549 Attn: Linda Cvrkel Re: Diamond Ranch Foods, Ltd. SEC Comment Letter dated January 30, 2008 Ms. Cvrkel: In response to the Commission?s comment letter dated January 30, 2008 regarding the Form 10-KSB for the fiscal year ended March 31, 2007 filed on behalf of Diamond Ranch Foods, Ltd. on June 29, 2007, the C |
|
| November 14, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-QSB (MARK ONE) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED: September 30, 2007 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-51206 Diamond Ranch |
|
| August 13, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-QSB (MARK ONE) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED: JUNE 30, 2007 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-51206 Diamond Ranch Foods |
|
| June 29, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-KSB ANNUAL REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2007 - Commission file number 000-51206 - DIAMOND RANCH FOODS, LTD. (Exact Name of Small Business Issuer in its charter) NEVADA 20-1389815 - - (State or other jurisdiction of (I.R.S. Employer incorpora |
|
| February 13, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-QSB (MARK ONE) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED: December 31, 2006 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-51206 Diamond Ranch F |
|
| November 14, 2006 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-QSB (MARK ONE) [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED: September 30, 2006 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-51206 Diamond Ranch |
|
| November 2, 2006 | ||
| October 27, 2006 | ||
| October 27, 2006 | ||
| May 16, 2005 |
555 West Street, New York, New York 10014 (212) 807-7600 telephone o (212) 807-7252 facsimile May 13, 2005 U.S. Securities and Exchange Commission Division of Corporation Finance 450 Fifth Street, N.W. Washington, D.C. 20549 ATTN: Barry McCarty or Kathryn McHale RE: Diamond Ranch Foods, Ltd. Form 10-SB filed March 15, 2005 File No. 000-51206 Dear Sir or Madam: This correspondence is submitted in response to your letter dated April 15, 2005 regarding the March 15, 2005 filing of Form 10-SB |
|
| March 16, 2005 |
Plandaí Biotechnology, Inc. Articles ARTICLES OF INCORPORATION OF DIAMOND RANCH FOODS, LTD. KNOW ALL ME BY THESE PRESENTS, that I, the undersigned, do hereby associate myself into a corporation under and pursuant to the provisions and by virtue of the laws of the State of Nevada, as provided in the Corporation Act of 1925, and all Acts amendatory thereof and supplemental thereto, and for that purpose do hereby make, subscribe, acknow |
|
| March 16, 2005 |
Plandaí Biotechnology, Inc. By-Laws DIAMOND RANCH FOODS, LTD. (A NEVADA CORPORATION) BYLAWS ARTICLE ONE: NAME AND OFFICES 1.01 NAME. The name of the corporation is DIAMOND RANCH FOODS, LTD., hereinafter referred to as the "Corporation." 1.02 REGISTERED OFFICE AND AGENT. The Corporation shall establish, designate and maintain a registered office and agent in the Stare of Nevada. The registered office of the Corporation shall be at 14 |
|
| March 16, 2005 |
As filed with the Securities and Exchange Commission on March 15, 2005 Registration No. |
